Back
Seritage Growth Properties Vs. Monopar Therapeutics Industry Stock Comparison
Sell
24
SRG
Seritage Growth Properties
Last Price:
$3.31
Seasonality Move:
-1.12%
Sell
46
MNPR
Monopar Therapeutics
Last Price:
$37.99
Seasonality Move:
-13.48%
Sell
24
Seritage Growth Properties (SRG)
is a Sell
Is Seritage Growth Properties a Buy, Sell or Hold?
-
The current Seritage Growth Properties [SRG] share price is $3.43. The Score for SRG is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
-
SRG is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Monopar Therapeutics (MNPR)
is a Sell
Is Monopar Therapeutics a Buy, Sell or Hold?
-
The current Monopar Therapeutics [MNPR] share price is $37.60. The Score for MNPR is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
MNPR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SRG Stock Price Chart
What is Seritage Growth Properties's stock price today?
-
The Seritage Growth Properties share price today is $3.43Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRG is experiencing buying pressure, which is a positive indicator for future bullish movement.
MNPR Stock Price Chart
What is Monopar Therapeutics's stock price today?
-
The Monopar Therapeutics share price today is $37.60The current trend is moderately bullish and MNPR is experiencing slight selling pressure.
SRG Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.09 | Sell |
Relative Strength Index (14 RSI): | 45.91 | Sell |
Chaikin Money Flow: | 147679 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.35 - 3.75) | Sell |
Bollinger Bands (100): | (3.61 - 4.31) | Sell |
MNPR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.33 | Buy |
Relative Strength Index (14 RSI): | 53.16 | Buy |
Chaikin Money Flow: | -4864 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (29.9 - 41.16) | Buy |
Bollinger Bands (100): | (18.89 - 38.95) | Buy |
SRG Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.41 | Buy |
20-day SMA: | 3.49 | Sell |
50-day SMA: | 3.67 | Sell |
200-day SMA: | 4.32 | Sell |
8-day EMA: | 3.41 | Buy |
20-day EMA: | 3.49 | Sell |
50-day EMA: | 3.67 | Sell |
200-day EMA: | 4.71 | Sell |
MNPR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 36.16 | Buy |
20-day SMA: | 33.55 | Buy |
50-day SMA: | 36.72 | Buy |
200-day SMA: | 16.35 | Buy |
8-day EMA: | 37.12 | Buy |
20-day EMA: | 35.96 | Buy |
50-day EMA: | 34.41 | Buy |
200-day EMA: | 21.02 | Buy |
Seritage Growth Properties Earnings Growth & SRG Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Monopar Therapeutics Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.50 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.70 per share, and an increase next year of $2.24 per share.
Seritage Growth Properties Technical Analysis
Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Monopar Therapeutics Technical Analysis
Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |